Evaluation of Infants Fed an Extensively Hydrolyzed Hypo Allergenic Infant Formula

NCT03597113 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 320

Last updated 2021-03-03

No results posted yet for this study

Summary

The purpose of this study is to evaluate the growth and compliance of an intended use population of infants receiving an extensively hydrolyzed infant formula.

Conditions

  • Gastrointestinal Tolerance

Sponsors & Collaborators

  • Abbott Nutrition

    lead INDUSTRY

Principal Investigators

  • Aysugul Alptekin, MD · Abbott Turkey

Eligibility

Min Age
0 Days
Max Age
180 Days
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-01-31
Primary Completion
2020-03-27
Completion
2020-03-27

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03597113 on ClinicalTrials.gov